Several cerebrospinal fluid biomarkers showed good accuracy in identifying patients with mild cognitive impairment who progressed to Alzheimer’s disease, according to a new study.
Several cerebrospinal fluid biomarkers showed good accuracy in identifying patients with mild cognitive impairment who progressed to Alzheimer’s disease, according to a new study.